Good News About Parkinson’s Disease And Medical Marijuana
Published in Cannabis Daily
Parkinson’s is in the news again – but there is a bit of hope with cannabis for those afflicted with the disease
Over 10 million people around the world suffer from this miserable disease. But there is good news about Parkinson’s disease and medical marijuana. A growing body of research is shedding light on how it may offer real hope for people living with the disease—a progressive nervous system disorder which affects movement and often includes tremors, stiffness, and balance issues. Recent studies from respected medical and academic institutions suggest that cannabis-based treatments may help relieve some of the most debilitating symptoms associated with the disease. One of the most promising areas is in managing non-motor symptoms such as sleep disturbances, anxiety, and pain. A 2022 study by the University of Colorado Anschutz Medical Campus found that cannabis use among Parkinson’s patients led to significant improvement in sleep and pain levels. The researchers noted that these improvements often translated to a better overall quality of life. Even more intriguing is the evidence suggesting that cannabinoids may help with motor symptoms such as tremors and rigidity. A study from Tel Aviv University and Rabin Medical Center in Israel, published in Clinical Neuropharmacology, found that patients who used cannabis reported a 30% to 50% improvement in tremor, rigidity, and bradykinesia (slowness of movement). https://www.urmc.rochester.edu/news/ While medical marijuana is not a cure for Parkinson’s, it is increasingly seen as a complementary therapy, especially when traditional medications come with unwanted side effects or fail to provide full relief. Dr. Benzi Kluger, a neurologist and Parkinson’s specialist at the University of Rochester Medical Center, supports further exploration: “We’re seeing enough anecdotal evidence and early data to warrant larger, more rigorous clinical trials.” Importantly, not all cannabis products are equal. Many experts recommend formulations high in cannabidiol (CBD) and low in tetrahydrocannabinol (THC) to reduce psychoactive effects while still providing symptom relief. As always, Parkinson’s patients should consult with their neurologist or a medical cannabis specialist before beginning any cannabis-based therapy. As public acceptance and legal access to medical marijuana grow, so does the opportunity to better understand its role in managing complex neurological conditions like Parkinson’s. Ongoing trials, such as those supported by the Parkinson’s Foundation and the Michael J. Fox Foundation, continue to investigate how cannabis could be integrated safely into long-term care plans. While much research is still needed, the latest findings offer a welcome dose of optimism for the millions affected by Parkinson’s disease—and point to a future where medical cannabis may be a mainstream part of symptom management.
The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit www.thefreshtoast.com.
Comments